Cordant Inc’s Bio-Techne TECH Stock Holding History

Cordant Inc’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20	Closed	-$2K	–	1121
2022 Q1	$2K	Buy	+20	New	+$2.06K	﹤0.01%	769

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Cordant Inc's TECH Position: Q2 2022 in Review

Cordant Inc sold out of Bio-Techne (TECH) in Q2 2022, closing a stake of 20 shares — an estimated $2K sold.

Cordant Inc first reported a position in TECH in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 550 funds tracked by Wall St. Rank hold TECH as of Q2 2022.

Cordant Inc reported no remaining Bio-Techne position as of Q2 2022 after selling out during the quarter.
Cordant Inc sold 20 Bio-Techne shares in Q2 2022, an estimated $2K.
Cordant Inc first reported a position in Bio-Techne in Q1 2022 and held it in 1 quarter.
Cordant Inc's Bio-Techne position peaked at $2K in Q1 2022.
550 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2022.

Based on Cordant Inc's 13F filing for Q2 2022, filed 17 Aug 2022.